mothertobaby semaglutide pregnancy fact sheet 2024 Semaglutide pregnancy risks: Experts call for more research Home Page - MotherToBaby

The central nervous system effects of GLP-1 receptor activation also contribute to gastrointestinal symptoms

For example, in clinical trials of Wegovy (semaglutide), eructation was reported in 5.8% of patients versus 0% in the placebo group

Another concern is the idea of relying on medication for weight loss

Why Combining GLP-1 Medications Is Usually Not Recommended Both medications belong to a group of therapies that influence incretin hormones, which help regulate appetite, digestion, and blood sugar levels

Lancet Neurol

Perhaps more likely is an indirect relationship, says Dr Riccardo Di Giorgi, a researcher at the University of Oxford who has also found promising cognitive signs in patients who use the drugs